Aug 11, 2025 04:51PM TELA Bio, Inc. (TELA) Misses Q2 EPS by 4c

Jun 3, 2025 04:07PM TELA Bio Inc. (TELA) Announces European Commercial Launch of OviTex Inguinal

Jun 2, 2025 08:30AM TELA Bio Inc. (TELA) Appoints Jeffrey Blizard as President

May 20, 2025 08:32AM Piper Sandler on TELA Bio, Inc. (TELA): 'Nice Rebound in Q1 but Still a Ways to Go'

May 8, 2025 07:42PM TELA Bio, Inc. (TELA) Misses Q1 EPS by 5c

Apr 9, 2025 06:35AM Canaccord Genuity Reiterates Buy Rating on TELA Bio, Inc. (TELA)

Mar 31, 2025 07:01AM TELA Bio Inc. (TELA) Announces U.S. Commercial Launch of Larger Sizes of OviTex® PRS for Plastic and Reconstructive Surgery

Mar 21, 2025 06:46AM TELA Bio, Inc. (TELA) PT Lowered to $7 at Canaccord Genuity

Mar 21, 2025 04:44AM TELA Bio, Inc. (TELA) PT Lowered to $7 at Citizens JMP

Mar 21, 2025 03:30AM Piper Sandler Downgrades TELA Bio, Inc. (TELA) to Neutral

Mar 20, 2025 04:57PM TELA Bio, Inc. (TELA) Misses Q4 EPS by 1c

Nov 8, 2024 08:09AM TELA Bio, Inc. (TELA) PT Lowered to $5 at Piper Sandler

Nov 7, 2024 04:49PM TELA Bio, Inc. (TELA) Misses Q3 EPS by 2c ; Offers Guidance

Oct 23, 2024 07:40AM Piper Sandler Reiterates Overweight Rating on TELA Bio, Inc. (TELA)

Oct 22, 2024 04:07PM TELA Bio Inc. (TELA) Announces Proposed Share and Warrant Offering

Oct 22, 2024 04:04PM TELA Bio Inc. (TELA) reports prelim Q3, announces cost cutting

Oct 4, 2024 06:49AM Canaccord Genuity Reiterates Buy Rating on TELA Bio, Inc. (TELA)

Aug 13, 2024 09:09AM TELA Bio, Inc. (TELA) PT Lowered to $8 at Piper Sandler

Aug 13, 2024 06:33AM TELA Bio, Inc. (TELA) PT Lowered to $12 at Canaccord Genuity

Aug 12, 2024 04:25PM TELA Bio, Inc. (TELA) Misses Q2 EPS by 5c, reiterates guidance